These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23893235)

  • 1. Top 10 developments in lupus nephritis.
    Chen TK; Fine DM
    Curr Rheumatol Rep; 2013 Sep; 15(9):358. PubMed ID: 23893235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent news in the treatment of lupus nephritis.
    Tesar V; Hruskova Z
    Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in the treatment of lupus nephritis.
    Fanouriakis A; Krasoudaki E; Tzanakakis M; Boumpas DT
    Mod Rheumatol; 2012 Nov; 22(6):803-13. PubMed ID: 22584472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lupus-nephritis--diagnosis and treatment].
    Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolate mofetil.
    Ahuja TS; Boughton J; Weiss V; Memon A; Remmers A; Rajaraman S
    Am J Med Sci; 2001 Sep; 322(3):166-9. PubMed ID: 11570784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and future therapies for lupus nephritis.
    Appel GB
    Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
    Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab, a viable alternative for induction therapy of active lupus nephritis.
    Zhou XJ; Zhao MH; Zhang H
    Rheumatology (Oxford); 2014 Sep; 53(9):1537-8. PubMed ID: 24729446
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen.
    Tedeschi B; Arnaud L; Hie M; Mathian A; Amoura Z
    Ann Rheum Dis; 2014 Feb; 73(2):474-5. PubMed ID: 24001887
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
    Navaneethan SD; Viswanathan G; Strippoli GF
    Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
    Condon MB; Ashby D; Pepper RJ; Cook HT; Levy JB; Griffith M; Cairns TD; Lightstone L
    Ann Rheum Dis; 2013 Aug; 72(8):1280-6. PubMed ID: 23740227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and maintenance therapy in proliferative lupus nephritis.
    Ponticelli C; Glassock RJ; Moroni G
    J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the management of lupus nephritis: let the treatment fit the patient.
    Bertsias G; Boumpas DT
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
    Walsh M; James M; Jayne D; Tonelli M; Manns BJ; Hemmelgarn BR
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):968-75. PubMed ID: 17702723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
    Rovin BH; Furie R; Latinis K; Looney RJ; Fervenza FC; Sanchez-Guerrero J; Maciuca R; Zhang D; Garg JP; Brunetta P; Appel G;
    Arthritis Rheum; 2012 Apr; 64(4):1215-26. PubMed ID: 22231479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring new territory: the move towards individualised treatment.
    Haubitz M
    Lupus; 2007; 16(3):227-31. PubMed ID: 17432112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus nephritis: a rituximab-based regimen might enable oral steroid avoidance in lupus nephritis.
    Killock D
    Nat Rev Rheumatol; 2013 Aug; 9(8):443. PubMed ID: 23797310
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel therapies of lupus nephritis.
    Schieppati A; Remuzzi G
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):156-61. PubMed ID: 18277148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.